Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10277-1 | Temsirolimus | LSM-4295 | 148191 | ||
10278-1 | Topotecan | Hycamtin | LSM-5662 | 60700 | |
10279-1 | Trichostatin A | LSM-43005 | |||
10280-1 | Triciribine | LSM-3810 | 65399 | ||
10281-1 | Vinorelbine | Navelbine | LSM-6302 | 5311497 | |
10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10283-1 | XRP44X | AG-G-87906 | LSM-4298 | 10339779 | |
10343-1 | Baicalein | LSM-6355 | 5281605 | ||
10344-1 | Olomoucine II | LSM-6356 | 10067756 | ||
10345-3 | Torkinib | PP242 | LSM-6357 | 57347681 | |
10346-1 | Valproic acid | Depakine | LSM-4620 | 3549980 | |
10348-1 | Z-Leu-Leu-Norvalinal | MG-115 | LSM-6358 | 9868928 | |
10501-1 | 2-deoxyglucose | 2-deoxy-D-glucose; 2-Desoxy-D-glucose; 2-DG | 9062 | ||
10502-1 | Bromopyruvic acid | 3-bromopyruvic acid; Bromopyruvate | 70684 | ||
10503-1 | Celecoxib | Celebrex; Celebra; Celecox; Onsenal; Solexa; SC-58635; YM-177 | 2662 | ||
10504-1 | Chk2 inhibitor II | BML-277 | 9969021 | ||
10505-1 | Chloroquine | 2719 | |||
10506-1 | Dichloroacetate | 25975 | |||
10507-1 | Disulfiram | Tetraethylthiuram disulfide; TETD | 3117 | ||
10508-1 | FTase Inhibitor I | B581 | 132887 | ||
10509-1 | GM6001 | Ilomastat; Galardin; GM-6001 | 132519 | ||
10510-1 | LY294002 | LY-294002 | 3973 | ||
10511-1 | Mebendazole | Vermox | 4030 | ||
10512-1 | Methylglyoxal | Acetylformaldehyde; Pyruvaldehyde | 880 | ||
10513-1 | Nelfinavir | Viracept | 64143 |